Search results
Marcelo Bielsa defends Uruguay players after Copa America brawl
Sky Sports· 2 hours agoUruguay coach Marcelo Bielsa defended his players involved in a clash with Colombian fans after...
Are Isas set for a Labour shake-up? Five experts give their verdict
This Is Money· 4 days agoWhen it comes to protecting wealth, Isas - both cash and stocks and shares versions - are often the...
Driving the future of CAR-T cell therapies
Nature· 1 day agoUsing a multipronged strategy, Celyad is driving the development of next-generation chimeric antigen receptor-T cell-based therapies to treat cancer.
Children’s Commissioner to visit migrant centre over safeguarding concerns
The Courier· 5 days agoA migrant processing centre in Kent will be visited by the Children’s Commissioner over concerns...
IMFINZI▼(DURVALUMAB) in combination with chemotherapy APPROVED IN GREAT BRITAIN for the treatment of...
PharmiWeb· 4 days agoThis decision means that durvalumab is now licenced in Great Britain in both the resectable and unresectable non-small cell lung cancer settings which further reinforces AstraZeneca’s bold ambition ...
Treatment of Crops by Electric Discharges - Nature
Nature· 1 day agoHENDRICK has described in the Scottish Journal of Agriculture (vol. i., 1918, pp. 41–51) the results of some extensive experiments on the treatment of growing ...
Press Briefing Gets Heated Over Neurologist Visiting White House
Rolling Stone via Yahoo News UK· 5 days agoDr. Kevin Cannard, a neurologist at Walter Reed National Military Medical Center...
The British Medical Association - Nature
Nature· 1 day agoThe president in his address made a strong plea for better housing conditions in the industrial centres, and insisted that an enormous amount of the time and money which is at present being ...
South West Donkey Sanctuary site closure confirmed
Somerset Live via Yahoo News UK· 7 days agoThe Donkey Sanctuary in Ivybridge, Devon is among the four in the UK that is set to close down after months of consultation with 57 workers at risk of...
Q32 Bio Announces Completion of Enrollment in the SIGNAL-AD Phase 2 Clinical Trial of Bempikibart...
PharmiWeb· 2 days agoBempikibart is a fully human anti-IL-7Rα antibody that is designed to re-regulate adaptive immune function by blocking IL-7 and TSLP signaling, both of which contribute to inflammation...
